Cebon JS - Search Results

1

Phase I trial of 131I-huA33 in patients with advanced colorectal carcinoma.

Chong G, Lee FT, Hopkins W, Tebbutt N, Cebon JS, Mountain AJ, Chappell B, Papenfuss A, Schleyer P, U P, Murphy R, Wirth V, Smyth FE, Potasz N, Poon A, Davis ID, Saunder T, O'keefe GJ, Burgess AW, Hoffman EW, Old LJ, Scott AM. Chong G, et al. Among authors: cebon js. Clin Cancer Res. 2005 Jul 1;11(13):4818-26. doi: 10.1158/1078-0432.CCR-04-2330. Clin Cancer Res. 2005. PMID: 16000579 Clinical Trial.

2

Monoclonal antibodies that recognize human granulocyte-macrophage colony-stimulating factor and neutralize its bioactivity in vitro.

Dempsey PJ, Layton JE, Duhrsen U, Nicola NA, Cebon J, Burgess AW, Morstyn G. Dempsey PJ, et al. Hybridoma. 1990 Dec;9(6):545-58. doi: 10.1089/hyb.1990.9.545. Hybridoma. 1990. PMID: 1706312

3

Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity.

Cebon J, Nicola N, Ward M, Gardner I, Dempsey P, Layton J, Dührsen U, Burgess AW, Nice E, Morstyn G. Cebon J, et al. J Biol Chem. 1990 Mar 15;265(8):4483-91. J Biol Chem. 1990. PMID: 2155231 Free article.

4

Haemopoietic growth factor control of normal and neoplastic cellular proliferation.

Burgess AW, Cebon J, Smith S. Burgess AW, et al. Biochem Soc Symp. 1989;55:57-68. Biochem Soc Symp. 1989. PMID: 2695090

5

Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassay.

Cebon J, Dempsey P, Fox R, Kannourakis G, Bonnem E, Burgess AW, Morstyn G. Cebon J, et al. Blood. 1988 Oct;72(4):1340-7. Blood. 1988. PMID: 3048442 Free article.

6

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.

Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I, McKendrick J, Toner G, Bradstock K, Lieschke M, Cruickshank S, Tomita DK, Hoffman EW, Fox RM, Morstyn G. Maher DW, et al. Ann Intern Med. 1994 Oct 1;121(7):492-501. doi: 10.7326/0003-4819-121-7-199410010-00004. Ann Intern Med. 1994. PMID: 7520676 Clinical Trial.

7

Comparative study of the pharmacokinetics and toxicity of high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy.

Basser RL, Sobol MM, Duggan G, Cebon J, Rosenthal MA, Mihaly G, Green MD. Basser RL, et al. J Clin Oncol. 1994 Aug;12(8):1659-66. doi: 10.1200/JCO.1994.12.8.1659. J Clin Oncol. 1994. PMID: 8040678 Clinical Trial.

8

Clinical promise of tumour immunology.

Scott AM, Cebon J. Scott AM, et al. Lancet. 1997 May;349 Suppl 2:SII19-22. doi: 10.1016/s0140-6736(97)90016-7. Lancet. 1997. PMID: 9164443 Review. No abstract available.

9

Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer.

Clarke K, Basser RL, Maher D, Morgan DJ, Cebon J, Fox RM, Hill JS, Alt C, Bartlett J, Geldard H, Kaye AH, Green MD. Clarke K, et al. Among authors: cebon j. J Clin Oncol. 1998 Jun;16(6):2181-7. doi: 10.1200/JCO.1998.16.6.2181. J Clin Oncol. 1998. PMID: 9626219 Clinical Trial.

10

Dose escalation study of carboplatin and cyclophosphamide with filgrastim support: a phase I study.

Toner GC, Green M, Bishop JF, McKendrick J, Cebon J, Sheridan WP, Lockbaum P, O'Byrne J, Fox RM. Toner GC, et al. Am J Clin Oncol. 1998 Jun;21(3):263-9. doi: 10.1097/00000421-199806000-00012. Am J Clin Oncol. 1998. PMID: 9626795 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters